Funds · SYRE

Who owns SYRE?

Institutional ownership of Spyre Therapeutics Inc. from Form 13F, Q2 2026

265 institutional managers reported holding Spyre Therapeutics Inc. (SYRE) in Form 13F filings for Q2 2026, with 95,817,421 shares worth $8.5B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 12,438,262 shares (+15.3%). 88 opened new positions and 21 sold out.

Funds holding
265
Value held
$8.5B
New / sold out
88 / 21
Net shares, same filers
+15.3%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of SYRE

FundValueShare of 13F holdingsSharesMove
FMR LLC$1.2B13.6%13,026,187Added
BlackRock, Inc.$578M6.8%6,506,605Added
Perceptive Advisors LLC$383M4.5%4,319,496Added
RTW Investments, LP$377M4.4%4,251,996Added
Paradigm Biocapital Advisors LP$341M4.0%3,840,778Added
Vanguard Capital Management LLC$306M3.6%3,448,681Added
State Street Corp$271M3.2%3,057,416Added
Venrock Adviser, LLC$265M3.1%2,985,448Trimmed
Price T Rowe Associates Inc$263M3.1%2,960,855Added
Driehaus Capital Management LLC$249M2.9%2,799,166Added
Geode Capital Management, LLC$239M2.7%2,562,265Added
Vanguard Portfolio Management LLC$207M2.4%2,330,098Added
Capital World Investors$206M2.4%2,315,553Added
Jupiter Topco LLC$196M2.3%2,206,936First report
TCG Crossover Management, LLC$169M2.0%1,900,582Unchanged
Tang Capital Management LLC$168M2.0%1,892,200Unchanged
Bank of America Corp$158M1.9%1,777,854Added
Adage Capital Partners GP, L.l.c.$153M1.8%1,722,300New
Wellington Management Group LLP$140M1.7%1,581,505Trimmed
Goldman Sachs Group Inc$131M1.5%1,478,059Added
Franklin Resources Inc$131M1.5%1,472,943Added
Remedium Capital Partners, LLC$130M1.5%1,464,169Added
Affinity Asset Advisors, LLC$114M1.3%1,279,134Unchanged
JPMorgan Chase & Co$98.9M1.1%1,093,026Added
Holocene Advisors, LP$90.1M1.1%1,015,170New

Share of 13F holdings is each fund's shares as a share of the 95,817,421 SYRE shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $2.2B and sold $768M; 102 added and 55 trimmed.

Schedule 13D and 13G filings on SYRE

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about SYRE ownership

Who owns SYRE stock?
265 institutional investment managers reported SYRE positions in their Form 13F filings for Q2 2026, holding 95,817,421 shares worth $8.5B in total. FMR LLC reported the largest position.
Are funds buying or selling SYRE?
In Q2 2026, 88 managers opened new SYRE positions, 102 added, 55 trimmed and 21 sold out. Managers that filed in both quarters added a net 12,438,262 shares.
How current is this SYRE institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to SYRE by CUSIP. Options are left out. SYRE news and filings · SYRE insider trades · Top funds